Rosetta Genomics tumbles as Aegis turns negative

|About: Rosetta Genomics Ltd. (ROSG)|By:, SA News Editor

Rosetta Genomics (ROSG -19.1%) slides hard on heavy volume.

The move appears to be attributable to Aegis, where analysts have downgraded the shares to Hold from Buy.

Price target is now $3.50 (from $10).